Natus Medical Incorporated 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 20, 2007
 
 
Natus Medical Incorporated
(Exact name of registrant as specified in its charter)
         
Delaware
 
000-33001
 
77-0154833
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
         
1501 Industrial Road, San Carlos, California 94070
(Address of principal executive offices) (Zip Code)
         
Registrant's telephone number, including area code: (650) 802-0400
         
Not applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
ITEM 2.02.  Results of Operations and Financial Condition.

On February 20, 2007 Natus Medical Incorporated (the “Company”) is issuing a press release and holding a conference call regarding its financial results for the fourth quarter and year ended December 31, 2006 and other financial information. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
 
(c) Exhibits.    
       
  Exhibit No. Description
       
  99.1 Press release of Natus Medical Incorporated dated February 20, 2007 describing the Company’s results for its fourth quarter and year ended December 31, 2006 and other financial information.

 

 
 
 
SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
    NATUS MEDICAL INCORPORATED
       
Date: February 20, 2007   By: /s/ Steven J. Murphy 
      Steven J. Murphy
      Vice President Finance and Chief Financial Officer

 
 

Index to Exhibits
 
  Exhibit No. Description
     
  99.1 Press release of Natus Medical Incorporated dated February 20, 2007 describing the Company’s results for its fourth quarter and year ended December 31, 2006 and other financial information.